<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/new-treatments/imlunestrant-abemaciclib-esr1-mutated-breast-cancer-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-20T12:00:00+00:00</news:publication_date>
      <news:title>FDA Approves New Drug Combination for ESR1-Mutated Advanced Breast Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/new-treatments/imlunestrant-abemaciclib-esr1-mutated-breast-cancer-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-20T12:00:00+00:00</news:publication_date>
      <news:title>ESR1 විකෘති සහිත උසස් අවධියේ පියයුරු පිළිකා සඳහා නව ඖෂධ සංයෝජනයකට FDA අනුමැතිය</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/new-treatments/levacetylleucine-ataxia-telangiectasia-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-20T12:00:00+00:00</news:publication_date>
      <news:title>First FDA-Approved Treatment for Ataxia-Telangiectasia Improves Movement in Phase 3 Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/new-treatments/levacetylleucine-ataxia-telangiectasia-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-20T12:00:00+00:00</news:publication_date>
      <news:title>ඇටැක්සියා-ටෙලන්ජියෙක්ටේසියා රෝගීන්ගේ ඇටැක්සියා තත්ත්වයට Levacetylleucine ඖෂධයට FDA අනුමැතිය</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/breakthroughs/first-gene-therapy-sanfilippo-syndrome-type-a-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-20T12:00:00+00:00</news:publication_date>
      <news:title>First Gene Therapy Approved for Children With Sanfilippo Syndrome Type A</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/breakthroughs/first-gene-therapy-sanfilippo-syndrome-type-a-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-20T12:00:00+00:00</news:publication_date>
      <news:title>සැන්ෆිලිපෝ සින්ඩ්‍රෝමය A වර්ගය සහිත ළමුන් සඳහා වූ ප්‍රථම ජාන ප්‍රතිකාරයට FDA අනුමැතිය</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/new-treatments/finerenone-type-1-diabetes-chronic-kidney-disease-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-17T15:23:02+00:00</news:publication_date>
      <news:title>FDA Approves Finerenone for Kidney Disease in Adults With Type 1 Diabetes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/new-treatments/finerenone-type-1-diabetes-chronic-kidney-disease-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-17T15:23:02+00:00</news:publication_date>
      <news:title>1 වන වර්ගයේ දියවැඩියාව සහිත වැඩිහිටියන්ගේ නිදන්ගත වකුගඩු රෝගය සඳහා Finerenone ඖෂධයට FDA අනුමැතිය</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/diagnostics-technology/panxeon-blood-test-early-pancreatic-cancer-detection</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-17T15:23:02+00:00</news:publication_date>
      <news:title>New Blood Test Detects Many Early Pancreatic Cancers — But It Is Not Ready for Routine Screening</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/diagnostics-technology/panxeon-blood-test-early-pancreatic-cancer-detection</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-17T15:23:02+00:00</news:publication_date>
      <news:title>නව රුධිර පරීක්ෂණයකින් මුල් අවධියේ අග්න්‍යාශ පිළිකා බොහොමයක් හඳුනා ගැනේ — නමුත් සාමාන්‍ය පරීක්ෂාව සඳහා තවමත් සූදානම් නැත</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/breakthroughs/a319-bispecific-antibody-lupus-phase-1</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-15T01:53:07+00:00</news:publication_date>
      <news:title>Off-the-Shelf Immune Therapy Shows Promising Remission Signals in Severe Lupus</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/breakthroughs/a319-bispecific-antibody-lupus-phase-1</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-15T01:53:07+00:00</news:publication_date>
      <news:title>කලින්ම නිෂ්පාදනය කර භාවිතයට සූදානම් කළ හැකි නව ප්‍රතිශක්තිකරණ ප්‍රතිකාරයකින් ලූපස් රෝග සමනය පිළිබඳ දිරිගන්වන සලකුණු</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/clinical-trials/teclistamab-high-risk-smoldering-myeloma-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-15T01:53:07+00:00</news:publication_date>
      <news:title>Powerful Myeloma Immunotherapy Produces Deep Responses Before Multiple Myeloma Becomes Symptomatic</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/clinical-trials/teclistamab-high-risk-smoldering-myeloma-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-15T01:53:07+00:00</news:publication_date>
      <news:title>රෝග ලක්ෂණ සහිත මල්ටිපල් මයිලෝමා ඇතිවීමට පෙර ලබාදුන් ප්‍රබල ප්‍රතිශක්තිකරණ ප්‍රතිකාරයකින් ඉහළ ප්‍රතිචාර</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/news/new-treatments/apitegromab-first-muscle-targeted-sma-treatment-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-15T01:53:07+00:00</news:publication_date>
      <news:title>FDA Approves First Treatment Designed to Directly Target Muscle Loss in Spinal Muscular Atrophy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://suwanews.sinethhospitals.com/si/news/new-treatments/apitegromab-first-muscle-targeted-sma-treatment-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Suwa News</news:name>
        <news:language>si</news:language>
      </news:publication>
      <news:publication_date>2026-09-15T01:53:07+00:00</news:publication_date>
      <news:title>ස්පයිනල් මස්කියුලර් ඇට්‍රොෆි (SMA) රෝගයේ මාංශ පේශි ක්ෂය වීම සෘජුව ඉලක්ක කරන ප්‍රථම ප්‍රතිකාරයට FDA අනුමැතිය</news:title>
    </news:news>
  </url>
</urlset>